Marksans Pharma Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Jun '25
    Mar '25
    Dec '24
    Sep '24
    Jun '24
    Total Qtr Revenue cr
    625.63
    724.98
    709.70
    652.98
    605.57
    Other Income Qtr Cr5.6416.5227.8511.0614.95
    Operating Revenues Qtr619.99708.46681.85641.92590.62
    Loading chart...
    Operating Expenses Qtr
    519.87
    582.70
    543.08
    506.24
    462.18
    Operating Profit Qtr
    100.12
    125.75
    138.76
    135.68
    128.44
    EBITDA Qtr Cr
    105.76
    142.27
    166.61
    146.74
    143.38
    Depreciation Qtr
    23.10
    22.74
    20.69
    19.51
    20.44
    Net Profit Qtr
    58.32
    90.55
    104.56
    96.72
    88.75
    Basic EPS Qtr
    1.29
    2.00
    2.31
    2.13
    1.96
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -